ARF is not required for apoptosis in Rb mutant mouse embryos

Current Biology

Volumn 12, Issue 2, 2002, Pages 159-163

  Tsai, Kenneth Y ^a,b   MacPherson, David ^a   Rubinson, Douglas A ^a,b   Crowley, Denise ^a,c   Jacks, Tyler ^a,c  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b HARVARD MIT DIVISION OF HEALTH SCIENCES AND TECHNOLOGY   (United States)

^c HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MAMMALIA;

ADENOSINE DIPHOSPHATE RIBOSYLATION FACTOR; PRIMER DNA; PROTEIN P53;

ANIMAL; APOPTOSIS; ARTICLE; CYTOLOGY; EMBRYO; GEL MOBILITY SHIFT ASSAY; GENETICS; IMMUNOHISTOCHEMISTRY; METABOLISM; MOUSE; MOUSE MUTANT; NICK END LABELING; NUCLEOTIDE SEQUENCE; TUMOR SUPPRESSOR GENE;

ADP-RIBOSYLATION FACTORS; ANIMALS; APOPTOSIS; BASE SEQUENCE; DNA PRIMERS; ELECTROPHORETIC MOBILITY SHIFT ASSAY; EMBRYO; GENES, RETINOBLASTOMA; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; MICE; MICE, MUTANT STRAINS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0037154006     PISSN: 09609822     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-9822(01)00659-5     Document Type: Article

References (33)

1. The retinoblastoma protein and cell cycle control
2. Requirement for a functional Rb-1 gene in murine development
3. Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis
4. Effects of an Rb mutation in the mouse
5. Dual roles of the retinoblastoma protein in cell cycle regulation and neuron differentiation
6. p53-dependent apoptosis produced by Rb-deficiency in the developing mouse lens
7. Mutation of E2f-1 suppresses apoptosis and inappropriate S phase entry and extends survival of Rb-deficient mouse embryos
8. E2F3 contributes both to the inappropriate proliferation and to the apoptosis arising in Rb mutant embryos
9. Loss of Rb activates both p53-dependent and independent cell death pathways in the developing mouse nervous system
10. Id2 is a retinoblastoma protein target and mediates signalling by Myc oncoproteins
11. Disruption of retinoblastoma protein family function by human papillomavirus type 16 E7 oncoprotein inhibits lens development in part through E2F-1
12. Key roles for E2F1 in signaling p53-dependent apoptosis and in cell division within developing tumors
13. p53-dependent apoptosis suppresses tumor growth and progression in vivo
14. Altered cell cycle regulation in the lens of HPV-16 E6 or E7 transgenic mice: Implications for tumor suppressor gene function in development
15. Distinct roles for E2F proteins in cell growth control and apoptosis
16. p14ARF links the tumour suppressors RB and p53
17. Induction of ARF tumor suppressor gene expression and cell cycle arrest by transcription factor DMP1
18. The alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2
19. The ARF/p53 pathway
20. E1A signaling to p53 involves the p19(ARF) tumor suppressor
21. Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization
22. Disruption of the ARF-Mdm2-53 tumor suppressor pathway in Myc-induced lymphomagenesis
23. INK4a/ARF mutations accelerate lymphomagenesis and promote chemoresistance by disabling p53
24. Dual inactivation of RB and p53 pathways in RAS-induced melanomas
25. Cooperative effects of INK4a and ras in melanoma susceptibility in vivo
26. Essential role for oncogenic Ras in turnout maintenance
27. Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF
28. Tumor surveillance via the ARF-p53 pathway
29. p19ARF links the tumour suppressor p53 to Ras
30. The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53
31. Loss of p53 but not ARF accelerates medulloblastoma in mice heterozygous for patched
32. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation
33. p19ARF is dispensable for oncogenic stress-induced p53-mediated apoptosis and tumor suppression in vivo